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YOUNG INVESTIGATORS AWARDS
406  Young Investigators Awards 
Competition: Physiology, 
Pharmacology, and Pathology
Monday, March 07, 2005, 9:15 a.m.-10:30 a.m.
Orange County Convention Center, Room 232A
9:15 a.m.
406-5 Intravenous Infusion of Mesenchymal Stem Cells 
During Early Reperfusion Enhances Regional Perfusion 
and Improves Ventricular Function in a Porcine Model of 
Acute Myocardial Function
Michael E. Halkos, Faraz Kerendi, Ning-Ping Wang, Rong Jiang, L. Susan Schmarkey, 
Bradley J. Martin, Arshed A. Quyyumi, Walter L. Few, Hajime Kin, Zhi-Qing Zhao, Robert 
A. Guyton, Jakob Vinten-Johansen, Emory University School of Medicine, Atlanta, GA
Background: The intramyocardial or intracoronary injection of bone marrow stem cells 
after acute MI (AMI) has proven efﬁcacious in improving regional perfusion and LV 
function. Using a closed-chest porcine model of AMI, this study tested the hypothesis 
that bone marrow-derived mesenchymal stem cells (MSCs) delivered intravenously (IV) 
during early reperfusion engraft in ischemic myocardium, augment neovascularization, 
and improve LV function 12 weeks post-infarction.
Methods: The proximal LAD was occluded for 75 min by an angioplasty balloon. At 15 
min of reperfusion, Yorkshire pigs randomly received 1 of 4 treatments: vehicle (Control, 
n=10), 1 x 106 MSCs/kg (1 mill, n=7), 3 x 106 MSCs/kg (3 mill, n=8), or 10 x 106 MSCs/kg 
(10 mill, n=8). MSCs were pre-labeled with DiI and DAPI ﬂuorescent markers. Myocardial 
ﬂow reserve (intracoronary adenosine) in scar and border tissue was determined 12 
weeks after AMI using 15µm microspheres. LV function was assessed at 12 weeks by 
pressure-volume analysis (impedance catheter).
Results: MSCs were observed in the scar zone of MSC-treated pigs 12 weeks after IV 
infusion and expressed muscle-speciﬁc proteins by immunohistochemistry. Flow reserve 
(ml/min/g tissue) in the scar zone was greater in the 1 mill (2.5 ± 0.3), 3 mill (2.9 ± 0.7), 
and 10 mill (2.9 ± 0.5) groups vs Control (1.1 ± 0.3, p<0.001). Flow reserve in the border 
zone was also enhanced in the MSC-treated groups vs Control (p<0.001). Vascular 
density (antibody to vWF) in the scar zone was 23% greater in the 1 and 3 mill groups, 
and 30% greater in the 10 mill group vs Control (p<0.05). Preload-recruitable stroke work 
(mmHg) was greater in the 3 mill (39 ± 4.3) and 10 mill (44 ± 2.4) groups, but not in the 1 
mill group, compared to Control (26 ± 4.0, p<0.05). Systolic performance (slope of end-
systolic pressure-volume relationship, mmHg/ml) was also greater in 3 mill (1.4 ± 0.1) and 
10 mill (1.5 ± 0.2) vs Control (1.0 ± 0.1, p<0.05).
Conclusion: In a chronic porcine model of AMI, MSCs delivered IV during early 
reperfusion engraft into ischemic myocardium, enhance regional perfusion, and improve 
global LV function in a dose-dependent manner. Functional improvements may be a result 
of enhanced neovascularization.
9:30 a.m.
406-6 Nocturnal Hemodialysis Restores Impaired Endothelial 
Progenitor Cell Biology in End-Stage Renal Disease
Subodh Verma, Shu-Hong Li, Christopher Chan, Toronto General Hospital, University of 
Toronto, Toronto, ON, Canada
Cardiovascular disease is the principal cause of death in patients with ESRD. 
Accumulating evidence suggests that nocturnal hemodialysis (NHD), in addition to 
providing improved uremic clearance, affords greater cardiovascular risk reduction in 
patients with ESRD. Endothelial progenitor cells (EPCs) play a critical role in vascular 
repair, and improving EPC number, survival and function represents a novel target for 
restoring cardiovascular homeostasis. We conducted a cross sectional study to test the 
hypothesis that augmentation of uremic clearance by NHD will improve EPC number and 
function, and EPC number and function is directly related to left ventricular geometry, 
blood pressure and uremia control in ESRD patients. The following three groups of age 
and gender matched patients were studied: healthy control (n=10); ESRD patients on CHD 
(n=12) and ESRD patients on NHD (n=10). EPC number was assessed in each group, 
as was EPC function using in-vitro migration assays. Left ventricular mass index (LVMI) 
was derived using 2D echocardiography in all ESRD patients, and correlations between 
EPC number, uremic clearance and LVMI were made.EPC number and function were 
markedly impaired in ESRD patients subjected to CHD [(EPCs number: 3.48 ± 1.2 vs. 
CHD 0.86 ± 0.20 % per 50,000 cells, p<0.05) and (EPC function: 18.8 ± 2.64 vs. CHD 3.75 
± 0.34 migrated cells per high power ﬁeld, p < 0.05)]. Importantly, these derangements in 
EPC biology were observed despite higher erythropoietin consumption, which is known to 
favorably modulate EPC survival. In contrast, EPC number and function were completely 
restored in ESRD patients subjected to NHD [(EPCs number: 3.48 ± 1.17 vs. NHD 3.83 
± 0.77 % per 50,000 cells, p > 0.05) and (EPC function: 18.8 ± 2.6 vs. NHD 22.2 ± 2.4 
migrated cells per high power ﬁled, p>0.05)]. Among ESRD patients EPCs number and 
function inversely correlated to pre-dialysis urea concentration. In addition EPC number 
and function inversely correlated to LVMI (r = -0.41, p<0.05; r = -0.46, p<0.05) and systolic 
blood pressure (r = -0.58, p<0.05; r = -0.44, p<0.05) in ESRD patients.We demonstrate 
that abnormal EPC biology in ESRD remains uncorrected following CHD, yet can be 
completely restored to normal by NHD
9:45 a.m.
406-7 Brief Renal Artery Occlusion and Reperfusion Applied 
Immediately Before Myocardial Reperfusion (“Remote 
Postconditioning”) Protects the Myocardium Against 
Reperfusion Injury Via Adenosine Receptor Activation
Faraz Kerendi, Hajime Kin, Michael E. Halkos, Rong Jiang, Zhi-Qing Zhao, Robert A. 
Guyton, Jakob Vinten-Johansen, Emory University School of Medicine, Atlanta, GA
Objectives: Recent investigations have shown that a brief series of intermittent reperfusion 
and reocclusion applied during the early minutes of coronary reﬂow (“postconditioning”) 
attenuates reperfusion injury. This study tested the hypothesis that a brief single episode 
of renal artery occlusion and reperfusion (RAOR) applied immediately before the onset 
of myocardial reperfusion (“remote postconditioning”) would also be cardioprotective by 
mechanisms involving adenosine.
Methods: Anesthetized rats undergoing 30 minutes of left coronary artery occlusion and 
3 hours of reperfusion were randomized to 6 groups: 1) CON (control, renal artery (RA) 
was isolated but not occluded); 2) RAOR (RA was occluded for 5 minutes and released 1 
minute before coronary reperfusion); 3) Permanent RAO (RA was occluded permanently 
5 minutes before coronary reperfusion, n=6); 4) Delayed RAOR (RA was occluded for 5 
minutes, but the release was delayed until 1 minute after onset of coronary reperfusion); 
5) CON+SPT (same as CON, but received 10 mg/kg 8-sulfophenyltheophylline [SPT], an 
adenosine receptor inhibitor) 5 minutes prior to the onset of coronary reperfusion); and 
6) RAOR+SPT (same as RAOR, but received 10 mg/kg SPT 5 minutes prior to coronary 
reperfusion). Infarct size is expressed as a percentage of the area at risk (mean ± SEM).
Results: Infarct size was reduced by 50% in RAOR (25 ± 4%) compared to CON (49 ± 
4%, p=0.003), conﬁrmed by plasma CK activity at end of reperfusion (44 ± 5 vs. 67 ± 6, 
p=0.023). In contrast, permanent RAO (47 ± 5%) failed to reduce infarct size. Delaying the 
release of RAO until 1 minute after coronary reperfusion (48 ± 6%) was not associated 
with the infarct size reduction observed with RAOR. Treatment with 8-SPT alone (47 
± 4%) did not alter infarct size compared to CON. However, 8-SPT+RAOR (50 ± 3%) 
negated the protective effect of RAOR.
Conclusions: Brief RAOR applied immediately before the onset of coronary reperfusion 
provides potent cardioprotection in a time-sensitive manner. In this study, remote renal 
postconditioning is likely mediated by a soluble factor released from the kidney that acts 
on myocardial adenosine receptors during the critical ﬁrst minute of reperfusion.
10:00 a.m.
406-8 Protection of Adult Rat Cardiomyocytes From Ischemic 
Cell Death: Role of Caveolar Microdomains and Opioid 
Receptor Subtypes
Hemal H. Patel, Brian Head, David Roth, Ingrid Niesman, Marilyn Farquhar, Garrett 
Gross, Paul Insel, University of Caliornia, San Diego, La Jolla, CA
Caveolae are membrane microenvironments enriched in signaling molecules whose role 
in cardioprotection is not well deﬁned. Cardioprotection is induced by opioid receptor (OR) 
stimulation but precise characterization of OR expression, localization, and trafﬁcking is 
lacking. We tested the hypothesis that OR subtypes localize to caveolae and induce 
cardioprotection, which depends on caveolar signaling in adult rat cardiac myocytes (ACM). 
mRNA and protein expression for delta-, mu-, and kappa-OR (D-, M, and K-OR, respectively) 
was detected in ACM. While the D- and M-ORs were found in buoyant caveolar fraction, 
K-ORs localized to fractions identiﬁed with intracellular markers. Immunohistochemistry 
conﬁrmed plasma membrane co-localization of D- and M-OR with caveolin-3, a structural 
protein in caveolae. In addition, we subjected ACM to ischemia (2hr) or a preconditioning 
(PC, 10min ischemia; 30min recovery; 2hrs ischemia) in the presence and absence (±) 
of methyl-beta-cyclodextrin (MBCD,1mM), a molecule that binds cholesterol and disrupts 
caveolae. We assessed the cardioprotective effects of SNC-121 (SNC), a D-OR agonist, 
± MBCD and MBCD preloaded with cholesterol. Ischemia, simulated by mineral oil 
layering to inhibit gas exchange of ACM, promoted cell death (trypan blue staining). SNC 
protected cells from ischemic injury (p<0.01 vs ischemia, 1mM SNC) as did PC (35±4 
vs 62±3, p<0.01, % cells dead). MBCD treatment attenuated the protective effects of PC 
or SNC, resulting in cell death comparable to the ischemic group. Cholesterol-saturated 
MBCD, which does not disrupt caveolae, had no effect on SNC-induced protection. MBCD 
treatment showed disruption of caveolae formation at the electron microscopy level. SNC-
stimulated cells had an altered D-OR distribution compared to control which was blocked 
by naloxone, an OR antagonist, and MBCD treatment but not cholesterol-saturated MBCD 
treatment. Based on the ability of MBCD treatment to attenuate the protective effect of 
PC and SNC and alter agonist-stimulated receptor redistribution, the ﬁndings suggest a 
key role for caveolae, perhaps through enrichment of signaling molecules, as an important 
determinant of cardioprotection.
10:15 a.m.
406-9 Vascular Endothelial Growth Factor Is Required 
for Coronary Collateral Growth Under Repetitive 
Myocardial Ischemia in the Rat
Eiji Toyota, Dept of Physiology, Louisiana State University Health Sciences Center, New 
Orleans, LA
Background: The goal of this study was to determine if the expression of vascular 
endothelial growth factor (VEGF) is critical for coronary collateral development.
Methods: We measured coronary collateral growth in rats subjected to repetitive 
episodes of myocardial ischemia (RI: one 40 sec occlusion every 20 min for 2 hrs 40 min 
followed by 5 hrs 20 min of rest, and repeating this 8 hr cycle 3 times per day for 10 days). 
Collateral growth was measured from blood ﬂow (radioactive microspheres), visualization 
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of arterial-arterial anastomoses (X-ray MicroCT), and maintenance of function during 
complete coronary occlusion in 3 groups of animals: sham (received instrumentation but 
no RI); experimental (subjected to RI), and anti-VEGF (RI + anti-VEGF 0.6 mg/100g per 
day) to block the endogenous actions of VEGF.
Results: In the three groups, native collateral ﬂow (measurement for RI or sham protocol) 
averaged 0.2-0.3 ml/min per g of tissue. In the sham group, collateral ﬂow did not increase 
during the protocol. Collateral ﬂow in the control RI group increased by about 6-fold to 
1.63 ml/min per g, but in the anti-VEGF group collateral ﬂow did not increase following 
the RI protocol (0.22 ml/min per g). X-ray micro-CT analysis revealed several visible 
arterial-arterial anastomoses following RI, but not in hearts of animals without RI or in 
anti-VEGF treated animals. The development of the collateral circulation was functional in 
the RI group because complete coronary occlusion did not induce any untoward effects 
on hemodynamics or arrhythmias. In the sham or anti-VEGF groups, coronary occlusion 
at the end of the protocol induced many arrhythmias, and deterioration of function.
Conclusion: Based on these results we conclude that the expression of VEGF is critical 
to the growth and development of coronary collaterals.
YOUNG INVESTIGATORS AWARDS
408  Young Investigators Awards 
Competition: Molecular and Cellular 
Cardiology
Monday, March 07, 2005, 11:00 a.m.-12:15 p.m.
Orange County Convention Center, Room 232A
11:00 a.m.
408-5 Rescue of Beta(2)-Adrenergic Receptor 
Overexpression-Induced Cardiomyopathy by Dominant-
Negative p38 Mitogen Activated Protein Kinase
Jennifer E. Brady, University of Medicine and Dentistry of New Jersey, Newark, NJ
Background: Whereas β-adrenergic receptor (β-AR) blockers are assuming increased 
importance in the treatment of heart failure, the cellular mechanism of these beneﬁcial 
effects is not entirely known. There are several transgenic mouse models of enhanced 
β-AR signaling that develop cardiomyopathy as they age. Since the mechanism of the 
cardiomyopathy in these models involves chronically enhanced β-AR signaling, we 
reasoned that determining the cellular mechanism that rescues the cardiomyopathy could 
also provide insight into the mechanism of β-AR blockade treatment in heart failure.
Methods: To accomplish this goal, we examined mice with β2-AR overexpression which 
demonstrate enhanced left ventricular function at a young age and develop impaired left 
ventricular function and cardiomyopathy as they age.
Results: In young mice (4-5 months) overexpressing the β2-AR (β2-AR TG), the left 
ventricular ejection fraction (LV EF) was 82 ± 0.02%, which was higher than young wild 
type (WT) (68 ± 0.2%, p < 0.001). In old β2-AR TG mice (10-17 months), LV EF fell to 53 
± 0.03% (p < 0.05), which was lower than old WT (71 ± 0.2%, p < 0.001). In old β2-AR TG 
mice there was increased ﬁbrosis by 10 fold, as quantiﬁed by picric sirius red, abnormal 
histological architecture, and increased apoptosis (TUNEL). Western blotting revealed that 
phosphorylated p38 MAPK was increased in young β2-AR TG compared with young WT by 
1.7 fold (p < 0.05). Similarly, phospho-p38 MAPK was increased in old β2-AR TG by 2.0 fold 
(p < 0.05) compared with old WT. Accordingly, we crossed β2-AR TG with dominant-negative 
p38α MAPK mice. In these mice, as expected, phospho-p38 MAPK was not increased 
compared with WT. Interestingly, in old β2-AR TG x DNp38α MAPK the cardiomyopathy was 
rescued, i.e. LV EF did not fall and remained at normal levels (77 ± 0.01%).
Conclusion: These results support the hypothesis that the cardiomyopathy, which 
develops in mice overexpressing the β2-AR, is due to activation of p38 MAPK. It is 
conceivable that this pathway could also be involved in the salutary effects of β-AR 
blockade therapy in patients with heart failure.
11:15 a.m.
408-6 Paracrine Action Accounts for Marked Protection of 
Ischemic Heart by Akt Modiﬁed Mesenchymal Stem Cells
Massimiliano Gnecchi, Huamei He, Nicolas Noiseux, Olin D. Liang, Lunan Zhang, Luis 
G. Melo, Richard E. Pratt, Joanne S. Ingwall, Victor J. Dzau, Brigham and Women’s 
Hospital, Boston, MA, Duke University Medical Center, Durham, NC
Background: We reported that transplantation of rat mesenchymal stem cells 
overexpressing Akt (Akt-MSC) limits ventricular remodeling and restores cardiac function 
2 weeks following myocardial infarction. Moreover we showed that the same therapeutic 
effects occur in less than 72 hours. Since this early protective effect cannot be attributed 
to myocardial regeneration, we hypothesised that a paracrine mechanism mediated by 
factor(s) secreted from Akt-MSC is involved. Accordingly, we tested the protective effect 
of conditioned medium from Akt-MSC both in vitro and in vivo.
Methods: Conditioned medium was collected from control MSC (GFP-MSC) and Akt-
MSC grown in normoxia (N-M) or exposed for 12 hours to hypoxia (H-M). Isolated adult 
rat ventricular cardiomyocytes (ARVC) were exposed to 24 hours of hypoxia in presence of 
either standard growth medium (CTR-M), N-M or H-M from GFP-MSC and N-M or H-M from 
Akt-MSC. Myocardial infarction was induced in rats by permanent ligation of the left coronary 
artery. After 30 minutes H-M from GFP- or Akt-MSC was injected in the heart. Sham and 
PBS-injected animals served as controls. At 72 hours cardiac function was measured with 
Langendorff preparation and infarct size was determined with TTC staining.
Results: Maximal protection on hypoxic ARVC was seen with H-M. Both GFP- and Akt-
MSC H-M signiﬁcantly decreased caspase 3 activity compared with CTR-M. However, 
the effect of Akt-MSC H-M was greater: compared with CTR-M and GFP H-M a reduction 
respectively of 78% (p<0.05) and 66% (p<0.05) was observed. Moreover, compared with 
CTR-M and GFP-MSCs H-M in the presence of Akt-MSC H-M there were respectively 
62% (p<0.05) and 54% (p<0.05) fewer TUNEL-positive ARVC. In vivo, Akt-MSC H-M 
signiﬁcantly increased left ventricular systolic pressure (Sham: 108±5; PBS: 72±6; GFP-
MSC H-M: 75±5; Akt-MSC H-M: 96±2, p<0.05 vs PBS and GFP-MSC H-M; values in 
mmHg). Infarct size was signiﬁcantly smaller in Akt-MSC H-M group (PBS: 33±5%; GFP-
MSC H-M: 29±4%; AKT-MSC H-M: 15±4%: p<0.05 vs PBS and GFP-MSC H-M).
Conclusion: We conclude that paracrine protective action by released factor(s) is a major 
mechanism in post-infarction healing process observed after Akt-MSC transplantation.
11:30 a.m.
408-7 Mutations in NOTCH1 Cause Congenital Cardiac 
Malformations
Vidu Garg, Marie K. Schluterman, Robert Barnes, Dennis E. Bulman, Paul D. Grossfeld, 
Jonathan C. Cohen, Deepak Srivastava, University of Texas Southwestern Medical 
Center, Dallas, TX
Background: Although advances have been made regarding the diagnosis and treatment 
of congenital heart disease (CHD), it remains the leading non-infectious cause of death 
in infants. CHD occurs in nearly 1% of live births, and this does not include the most 
common cardiac malformation, bicuspid aortic valve (BAV), which alone has an incidence 
of 1-2%. Aortic valve abnormalities such as a BAV predispose individuals to progressive 
aortic valve disease that when severe, requires surgical valve replacement. To date, no 
genetic etiologies of congenital aortic valve malformations have been identiﬁed.
Methods: A large kindred and 54 unrelated subjects with CHD were recruited for genetic 
analyses in accordance with IRB approved protocols. Genomic DNA was obtained, and 
whole-genome linkage analysis was performed. Direct sequencing of NOTCH1 was 
performed to identify genetic variations. Allelic discrimination assays were performed to 
screen for NOTCH1 sequence variations in control subjects.
Results: Here, we show that aortic valve disease in a large pedigree with 11 affected 
family members was linked to chromosome 9q34 (LOD score = 3.5). A heterozygous 
R1108X nonsense mutation of NOTCH1 was found in all affected family members but 
not in unaffected family members or 1,137 control individuals. NOTCH1 encodes a 
receptor involved in a highly conserved intercellular signaling pathway important for cell 
fate determination and is expressed in the embryonic heart. Screening of 54 individuals 
with similar types of CHD led to the identiﬁcation of two additional mutations in NOTCH1. 
In a subject with familial aortic valve disease, we identiﬁed a single base pair deletion in 
NOTCH1 that resulted in a frameshift mutation and premature truncation of the protein 
(H1505del). This heterozygous H1505del mutation segregated with the affected family 
members with BAV. Furthermore, a heterozygous missense mutation (R2273C) of 
NOTCH1 was found in a subject with non-familial complex CHD. Neither the H1505del 
nor the R2273C mutations of NOTCH1 were identiﬁed in 1,138 control individuals.
Conclusion: These ﬁndings implicate NOTCH1 as a genetic cause of human aortic valve 
malformations and associated CHD.
11:45 a.m.
408-8 Dose-Dependent Contribution of CD34-Positive Cell 
Transplantation to Cardiomyogenesis, Vasculogenesis 
and Arteriogenesis With Functional Recovery Post 
Myocardial Infarction
Hiroto Iwasaki, Atsuhiko Kawamoto, Masakazu Ishikawa, Akira Oyamada, Shuko 
Nakamori, Hiromi Nishimura, Kazuyo Sadamoto, Miki Horii, Satoshi Murasawa, 
Toshihiko Shibata, Shigefumi Suehiro, Takayuki Asahara, Kobe Institute of Biomedical 
Research and Innovation, Kobe, Japan, RIKEN Center for Developmental Biology, Kobe, 
Japan
Background: Transformation capacity of the CD34+ cells into cardiomyocyte (CMCs) 
and smooth muscle cells (SMCs) is still controversial. Here, we performed a series of 
experiments to prove our hypothesis that cardiomyogenesis and arteriogenesis post 
myocardial infarction (MI) may be dose-dependently enhanced following CD34+ cell 
transplantation.
Methods: Peripheral blood CD34+ cells were isolated from total mononuclear cells of a 
patient with critical limb ischemia by apheresis after 5-day administration of G-CSF, using 
a magnetic cell sorting system. PBS, 1x103 CD34+ cells (Low), 1x105 CD34+ cells (Mid) 
or 5x105 CD34+ cells (High) were intramyocardially transplanted 20 min after ligating LAD 
of nude rats (n=12 in each group). Functional, histological and gene expression outcomes 
were compared among the groups.
Results: Functional assessments using echocardiography and a micro-tip conductance 
catheter at day 28 revealed dose-dependent preservation of LV function by CD34+ cell 
transplantation. Necropsy examination at day 28 disclosed dose-dependent augmentation 
of capillary density by isolectin B4 staining (High group, 714.3±25.0; Mid group, 535.8±31.0; 
Low group, 320.9±36.0; PBS group, 291.3±19.0 /mm2 respectively. P<0.01 for High vs Mid 
and Mid vs Low) and dose-dependent inhibition of LV remodeling by assessing % ﬁbrosis 
area (High group, 16.0±2.6; Mid group, 22.4±1.9; Low group, 30.7 ±3.9; PBS, 31.5±0.7% 
respectively. P<0.01 for High vs Mid and Mid vs Low groups). Immunohistochemistry for 
human-speciﬁc BNP demonstrated that human CMCs were more frequently observed in 
ischemic myocardium at day 28 in High and Mid groups than Low group. Immunostaining 
for smooth muscle actin and human leukocyte antigen or Ulex europaeus lectin type 1 
also revealed dose-dependent vasculogenesis and arteriogenesis following CD34+ cell 
transplantation. RT-PCR indicated that human speciﬁc gene expression of CMC, SMC 
and endothelial cell markers were dose-dependently augmented in MI tissue.
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Conclusion: CD34+ cell transplantation may have signiﬁcant and dose-dependent 
potential for cardiomyogenesis, vasculogenesis and arteriogenesis with functional 
recovery from MI.
Noon
408-9 Common Mechanisms in Leprosy and Atherosclerosis
Daniel Cruz, Dennis Jay Montoya, Antonio Castrillo, Joshua Bleharski, Peter Sieling, 
Philip Liu, Alan Wagner, Rita Chuang, Thomas Rea, Alan Fogelman, Peter Tontonoz, 
Judith Berliner, Robert Modlin, University of California, Los Angeles, Los Angeles, CA, 
University of Southern California, Los Angeles, CA
Background: The pathogenesis of atherosclerosis and intracellular pathogens involve an 
activated immune system. Evidence has accumulated that a T helper 1 cytokine proﬁle 
is pro-atherogenic, while a T helper 2 cytokine proﬁle can result in more stable plaque 
formation. Leprosy is a disease characterized by a spectrum of clinical manifestations: 
disseminated leprosy is characterized by expression of Th2 cytokines and foamy 
macrophages reminiscent of those found in atherosclerotic plaque, while the limited form 
of leprosy is characterized by a strong Th1 response. We hypothesized that understanding 
the mechanisms that generate a Th2 response in leprosy may yield important insights into 
atherogenesis and potential targets for plaque stabilization.
Methods: We analyzed a gene microarray database from disseminated, lepromatous 
leprosy (L-lep) and limited, tuberculoid leprosy (T-Lep) leprosy lesions for potential 
molecular pathways that may be relevant to atherosclerosis and plaque stabilization. 
Additionally, we examined the link between foam cell accumulation in L-lep lesions and 
atherosclerosis by using an immunohistochemical approach with antibodies against 
oxidized lipids known to be deposited in atherosclerosis.
Results: T-lep lesions express genes known to be pro-atherogenic, while L-lep lesions 
are characterized by expression of known atheroprotective genes. We demonstrate 
that mycobacteria can activate PPAR-γ target genes, and that PPAR activation is 
partly responsible for the CD1 downregulation that may contribute to immune evasion. 
Immunohistochemistry with EO6 reveals that L-lep, but not T-lep lesions, are associated 
with intense oxidized phospholipid accumulation. Mass spectrometry of macrophages 
infected by mycobacteria demonstrates accumulation of PEIPC, which is found in 
atheroma, and we show it to have anti-inﬂammatory properties.
Conclusions: Given the striking similarities between leprosy and atherosclerosis, 
elucidating the mechanisms involved in the pro- and anti-inﬂammatory properties in the 
polar forms of leprosy may reveal novel targets for plaque stabilization in atherosclerosis.
YOUNG INVESTIGATORS AWARDS
409  Young Investigators Awards 
Competition: Clinical Investigators-
-Cardiology and Cardiovascular 
Surgery
Monday, March 07, 2005, 2:00 p.m.-3:15 p.m.
Orange County Convention Center, Room 232A
2:00 p.m.
409-5 Metabolomic Identiﬁcation of Novel Biomarkers of 
Myocardial Ischemia
Marc S. Sabatine, Emerson Liu, David A. Morrow, Eric Heller, Manor Askenazi, Robert 
E. Gerszten, Brigham and Women’s Hospital, Boston, MA, Massachusetts General 
Hospital, Boston, MA
Background: Biomarkers that detect myocardial ischemia in the absence of necrosis 
would be of high clinical value. Advances in metabolic proﬁling offer a method to identify 
novel biomarkers and activated pathways in ischemia.
Methods: Plasma was obtained before & after exercise testing in 18 patients w/ ischemia 
(ISC) & 18 w/o (CON) as assessed by perfusion imaging. Plasma was fractionated 
by HPLC and proﬁling of metabolites was performed w/ a triple quadrupole mass 
spectrometer.
Results: Lactic acid (P<0.0001) and a cluster of metabolites involved in skeletal muscle 
AMP catabolism, including hypoxanthine (P=0.0004) & inosine (P=0.003), rose after 
exercise in both ISC & CON (Fig 1). In contrast, citric acid & urea cycles metabolites 
decreased after exercise only in ISC, including citric acid (P=0.02), oxaloacetate (P=0.03), 
citrulline (P=0.009), and argininosuccinate (P=0.024). Six metabolites were signiﬁcantly 
discordantly regulated in CON vs ISC, including GABA (P=0.0005), uric acid (P=0.0006), 
citric acid (P=0.0082) and unknown metabolites MET288, MET200, and MET193 
(P<0.0082 for each). By assigning patients 1 point for each metabolite that exceeded 
the ischemia cutpoint, we were able to differentiate CON vs ISC with a high degree of 
accuracy (Fig 2, P<0.0001, c-statistic=0.95).
Conclusions: We report the ﬁrst application of metabolomics to acute myocardial 
ischemia in which we identiﬁed novel biomarkers of ischemia and coordinate changes in 
groups of functionally related metabolites. 
2:15 p.m.
409-6 A Blood Pressure-Genotype Interaction in Corin Is 
Associated With an Increased Risk of Left Ventricular 
Hypertrophy in Untreated Hypertension
J. Eduardo Rame, Mark H. Drazner, Wendy Post, Joao Lima, Sabine Knappe, Qingyu 
Wu, Daniel L. Dries, Johns Hopkins University School of Medicine, Baltimore, MD, 
University of Texas Southwestern Medical Center, Dallas, TX
Background: Left ventricular hypertrophy (LVH) is a known predictor of cardiovascular 
events, including heart failure. The natriuretic peptide system has been invoked in 
physiologic counter-regulation promoting vasodilatation, natriuresis, and attenuating 
cardiac hypertrophy and ﬁbrosis. We hypothesized that individuals who are genotype 
positive for two novel non-synonymous non-conservative single nucleotide polymorphisms 
in complete linkage disequilibrium in corin, the pro-ANP/BNP convertase, would be 
susceptible to the development of LVH as a result of a modiﬁcation of the left ventricular 
mass (LVM)-systolic blood pressure (SBP) relation. 
Methods: Individuals with comparable cardiac MRI measurements to determine LVM in 
the Dallas Heart Study (DHS) and in the Multi-Ethnic Study of Atherosclerosis (MESA), 
our replication sample, were genotyped at the T555I/Q568P locus using a TaqMan 
assay. Multivariate linear regression models were used to determine the presence of an 
interaction between SBP and corin genotype on LVM in African Americans--the group in 
which the variant was almost exclusively present with a prevalence ~12%--who were not 
on anti-hypertensive medication in DHS (N=913) and MESA (N=636). 
Results: A positive and signiﬁcant interaction between corin genotype and SBP on LVM was 
identiﬁed in the DHS (p=0.005) and MESA (p=0.006), independent of relevant covariates 
and measures used to adjust for body size. Individuals with the corin variant have an excess 
increase in LVM of 4 grams per 10 mm Hg of SBP when compared to wild-type. A signiﬁcant 
increase in prevalent LVH (40.0% versus 18.6%, p=0.01) was also identiﬁed in the group of 
untreated hypertensives who were positive for the corin variant, as compared to the group 
of untreated hypertensives without a copy of the corin minor allele. 
Conclusion: Strong evidence exists that African-Americans who are genotype positive 
for the corin variant are more susceptible to developing LVH in the setting of untreated 
hypertension than their wild-type counterparts. This increased susceptibility may be the 
result of a modiﬁcation of the LVM-SBP relation enhancing the hypertrophic response to 
increased afterload.
2:30 p.m.
409-7 Proteomic Proﬁle of Peripheral Arterial Disease
Nandini Nair, Xiao-Ying Meng, Laurel DeLapp Waring, Fujun Zhang, Ben Varasteh, Eric 
T. Fung, John P. Cooke, Stanford University School of Medicine, Stanford, CA
Background: Peripheral arterial disease is underdiagnosed and undertreated. A blood 
test for PAD would signiﬁcantly enhance management of these patients. We hypothesized 
that these patients regularly experience episodes of ischemia-reperfusion while walking, 
which may be manifested by alterations in microvascular proteins released into the 
systemic circulation.
Methods: Plasma samples were collected before, immediately after, and 2 hrs after an 
exercise treadmill test , from 20 PAD patients and 11 age matched controls. Four of the 
PAD patients were classiﬁed as “long claudicators” based on an absolute claudication 
time > 12 minutes. Control subjects underwent 15 minutes of treadmill exercise. Plasma 
samples underwent high throughput proteomic proﬁling using surface enhanced laser 
desorption and ionization time-of-ﬂight spectroscopy (SELDI-TOF).
Results: Analysis of spectra by signiﬁcance analysis of microarrays software (SAM) 
revealed nineteen upregulated proteins. Seven of these proteins have been identiﬁed as 
triple charge (modiﬁed) albumin, alpha 1B glycoprotein, albumin, kappa chain of IgG, 
dimer of alpha 1 antitrypsin and fetuin ( alpha 2 glycoprotein). Notably, these proteins 
were elevated under basal conditions, and differentially regulated with exercise.
Conclusion: We present evidence for nineteen proteins that are differentially regulated 
in PAD, seven of which have been identiﬁed. The SELDI-TOF technique has been applied 
for the ﬁrst time in PAD to identify potential biomarkers.
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409-8 Peri-infarct Ischemia Determined by Comprehensive MR 
Evaluation of Myocardial Viability and Stress Perfusion 
Predicts Future Cardiovascular Events in Patients With 
Severe Ischemic Cardiomyopathy
Miwako Tsukiji, Patricia Nguyen, Girish Narayan, Jeffrey Hellinger, Frandics Chan, 
Robert Herfkens, Michael V. McConnell, Phillip Yang, Stanford University, Stanford, CA
Background: There is a high mortality rate in ischemic cardiomyopathy (ICM) patients 
with severe left ventricular (LV) dysfunction. The presence of peri-infarct ischemia has 
been associated with a high incidence of cardiovascular events. The purpose of this 
investigation is to assess whether MR assessment of peri-infarct ischemia provides 
prognostic information in patients with severe ICM considerd for revascularization.
Methods: Twenty-ﬁve patients (23 men, 2 women, mean LVEF 26±13%) with ICM recently 
diagnosed with severe coronary artery disease (three vessel, left main, or two vessel with 
proximal left anterior decsending artery) were recruited prospectively for MR delayed 
enhanced and stress perfusion studies prior to undergoing revascularization or medical 
therapy +/- implantable cardiac deﬁbllator (ICD) placement. Myocardial stress perfusion 
(FGRE-ET: Fast Gradient Echo-EchoTrain, TR 6.6, TE 1.2, TI 180) was performed with 0.05 
mmol/kg Gd-DTPA bolus during adenosine-induced stress (140 mcg/kg/min for 4 minutes) 
followed by delayed enhanced study (segmented k-space inversion recovery, TR 7.1, TE 
3.1, TI 200-250) 20 to 30 min after administration of Gd-DTPA (0.2 mmol/kg). The study was 
completed with rest myocardial perfusion using 0.1 mmol/kg Gd-DTPA bolus. The patients 
were followed for in-hospital complications (ventricular arrythmia or cardiac death) and 
post-discharge hospitalization due to coronary artery revascularization, unstable angina, 
myocardial infarction, worsening congestive heart failure, or cardiac death.
Results: During a mean of 8 months follow-up, 80% of the patients with peri-infarct 
ischemia and 15% of the patients without peri-infarct ischemia had cardiovascular events 
(p < 0.05). The measurement of total scar volume and scar percent of LV volume (scar/LV 
volume) did not correlate with cardiovascular events.
Conclusions: In patients with severe ICM, the presence of peri-infarct ischemia 
determined by cardiac MRI was associated with a higher incidence of cardiovascular 
events.
3:00 p.m.
409-9 The Large Majority of Sudden Cardiac Death Cases 
Do Not Have Severe Left Ventricular Dysfunction: 
A Prospective, Two-Year Evaluation in a Large US 
Community
Eric C. Stecker, Catherine Vickers, Justin Waltz, Monika Arora, Kalpana Narapasetty, 
Benjamin T. John, Ron Mariani, Karen Gunson, Jonathan Jui, John H. McAnulty, Sumeet 
S. Chugh, Oregon Health and Science University, Portland, OR
Background: Severe LV dysfunction is the major indication for primary prevention with 
the ICD, but the prevalence of this condition among SCD cases in the general population 
has not been evaluated. This would also be an essential ﬁrst step for the determination 
of additional/novel risk predictors among SCD cases that do not have severe LV 
dysfunction.
Methods: All cases of SCD in Multnomah County, OR (population 660,486) between 
January 31, 2002 and February 1, 2004 were prospectively determined and evaluated 
in the ongoing Oregon Sudden Unexplained Death Study (Ore-SUDS). We assessed 
the distribution of LV function among subjects who underwent echocardiography or 
ventriculography prior to SCD. LV function was categorized based on ejection fraction 
(normal >55%, mildly reduced 46-55%, moderately reduced 36-45% and severely reduced 
<35%). A detailed analysis of alternative risk markers of SCD was also conducted.
Results: During this two-year period, 722 residents of Multnomah County suffered SCD 
(biennial incidence 109 cases / 100,000 residents). Of 240 patients who underwent clinical 
evaluation prior to SCD, LVEF was assessed in 133 (55%). LVEF was severely reduced 
in only 30% (n=40), and 8% (n=11) had a prior history of SCD. Only 35% (n=47) would 
have been eligible for primary or secondary prevention with the ICD. The subgroup of SCD 
patients with normal LV EF had a signiﬁcantly younger mean age (normal LV EF - 64 ± 17 
years, reduced LV EF - 70 ± 12 years, p=0.014), higher proportion of women (normal LV 
EF - 50%, reduced LV EF - 30%, p=0.021), higher proportion of seizure disorder (normal 
LV EF - 10%, reduced LV EF - 0%, p=0.009) and lower proportion of CAD (normal LV EF 
- 37%, reduced LV EF - 76%, p<0.001).
Conclusions: A minority of SCD cases (35%) had severe LV dysfunction or other 
indications for ICD implantation. Subjects with normal LV function were distinguishable 
by younger age, female gender, seizure disorders and less coronary artery disease. Our 
observations underscore the critical need for SCD risk predictors other than severe LV 
dysfunction.
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